{
    "eid": "2-s2.0-85086842475",
    "title": "Immunogenicity and safety of the AS04-HPV-16/18 and HPV-6/11/16/18 human papillomavirus vaccines in asymptomatic young women living with HIV aged 15\u201325 years: A phase IV randomized comparative study",
    "cover-date": "2020-06-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Medicine (all)",
            "@code": "2700",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "4-valent HPV vaccine",
        "AS04-HPV-16/18 vaccine",
        "HIV",
        "HPV",
        "Immunogenicity",
        "Safety",
        "Vaccine"
    ],
    "authors": [
        "Nicolas Folschweiller",
        "Julio Teixeira",
        "Smita Joshi",
        "Luciano Z. Goldani",
        "Khuanchai Supparatpinyo",
        "Partha Basu",
        "Tawee Chotpitayasunondh",
        "Ploenchan Chetchotisakd",
        "Kiat Ruxrungtham",
        "Cecilia Roteli-Martins",
        "Beatriz Grinsztejn",
        "Silvana Maria Quintana",
        "Nagalingeswaran Kumarasamy",
        "Selvamuthu Poongulali",
        "Vinay Kulkarni",
        "Lan Lin",
        "Sanjoy K. Datta",
        "Dominique Descamps",
        "Monique Dodet",
        "Gary Dubin",
        "Damien Friel",
        "Marjan Hezareh",
        "Naveen Karkada",
        "Dorothee Meric Camilleri",
        "Sylviane Poncelet",
        "Bruno Salaun",
        "Fernanda Tavares-da-Silva",
        "Florence Thomas-Jooris",
        "Frank Struyf"
    ],
    "citedby-count": 9,
    "ref-count": 28,
    "ref-list": [
        "Human papillomavirus is a necessary cause of invasive cervical cancer worldwide",
        "Epidemiologic classification of human papillomavirus types associated with cervical cancer",
        "Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study",
        "Human papillomavirus, human immunodeficiency virus and immunosuppression",
        "Persistence of human papillomavirus infection in HIV-infected and -uninfected adolescent girls: risk factors and differences, by phylogenetic type",
        "Comparison of the immunogenicity and safety of Cervarix and Gardasil human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18-45 years",
        "Comparison of long-term immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine in healthy women aged 18-45 years: end-of-study analysis of a Phase III randomized trial",
        "Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and 4vHPV vaccine administered according to two- or three-dose schedules in girls aged 9-14years: results to month 36 from a randomized trial",
        "Comparison of adaptive and innate immune responses induced by licensed vaccines for human papillomavirus",
        "Post-hoc analysis from Phase III trials of human papillomavirus vaccines: considerations on impact on non-vaccine types",
        "CHAPTER 5 hpv infection and HPV-associated neoplasia in immunocompromised women",
        "Safety and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine in HIV-positive women in South Africa: a partially-blind randomised placebo-controlled study",
        "Safety and immunogenicity of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine in HIV-infected children 7 to 12 years old",
        "Four-year persistence of type-specific immunity after quadrivalent human papillomavirus vaccination in HIV-infected children: effect of a fourth dose of vaccine",
        "Immunogenicity and safety of the quadrivalent human papillomavirus vaccine in HIV-1-infected women",
        "Comparison of the immunogenicity and reactogenicity of Cervarix and Gardasil human papillomavirus vaccines in HIV-infected adults: a randomized, double-blind clinical trial",
        "Cellular immunogenicity of human papillomavirus vaccines Cervarix and Gardasil in adults with HIV infection",
        "The efficacy of the quadrivalent human papillomavirus vaccine in girls and women living with human immunodeficiency virus",
        "Human papillomavirus vaccination in HIV-infected women: need for increased coverage",
        "Enhanced humoral and memory B cellular immunity using HPV16/18 L1 VLP vaccine formulated with the MPL/aluminium salt combination (AS04) compared to aluminium salt only",
        "Changes in the prevalence of human papillomavirus following a national bivalent human papillomavirus vaccination programme in Scotland: a 7-year cross-sectional study",
        "Reactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18"
    ],
    "affiliation": [
        {
            "affiliation-city": "Wavre",
            "@id": "60111446",
            "affilname": "GlaxoSmithKline Pharmaceuticals SA/NV",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60111446",
            "affiliation-country": "Belgium"
        },
        {
            "affiliation-city": "Chennai",
            "@id": "60099668",
            "affilname": "The Voluntary Health Services, Chennai",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60099668",
            "affiliation-country": "India"
        },
        {
            "affiliation-city": "Campinas",
            "@id": "60029570",
            "affilname": "Universidade Estadual de Campinas",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60029570",
            "affiliation-country": "Brazil"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Rio de Janeiro",
            "@id": "60023997",
            "affilname": "Instituto Nacional de Infectologia Evandro Chagas (INI)",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60023997",
            "affiliation-country": "Brazil"
        },
        {
            "affiliation-city": "Kolkata",
            "@id": "60018972",
            "affilname": "Chittaranjan National Cancer Institute",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018972",
            "affiliation-country": "India"
        },
        {
            "affiliation-city": "Santo Andre",
            "@id": "60018756",
            "affilname": "Centro Universit\u00e1rio FMABC",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018756",
            "affiliation-country": "Brazil"
        },
        {
            "affiliation-city": "Khon Kaen",
            "@id": "60017165",
            "affilname": "Khon Kaen University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60017165",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Porto Alegre",
            "@id": "60014120",
            "affilname": "Hospital de Clinicas de Porto Alegre",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60014120",
            "affiliation-country": "Brazil"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60010778",
            "affilname": "Queen Sirikit National Institute of Child Health",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60010778",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Sao Paulo",
            "@id": "60008088",
            "affilname": "Universidade de S\u00e3o Paulo",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60008088",
            "affiliation-country": "Brazil"
        },
        {
            "affiliation-city": "Chaing Mai",
            "@id": "60000881",
            "affilname": "Chiang Mai University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60000881",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Pune",
            "@id": "114420582",
            "affilname": "Jehangir Clinical Development Centre",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/114420582",
            "affiliation-country": "India"
        },
        {
            "affiliation-city": "Singapore City",
            "@id": "101364830",
            "affilname": "GSK",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/101364830",
            "affiliation-country": "Singapore"
        }
    ],
    "funding": []
}